All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

@theskinandlashlady's HRT acne claims need context

Lic. Esthetician Amy

TikTok creator

7.4K viewsWatch on TikTok→

Quick answer

Testosterone therapy in women can increase sebaceous gland activity and trigger acne, particularly when doses push androgen levels above physiologic female ranges. Dose reduction is a reasonable first clinical step, but dermatological options including topical retinoids and spironolactone have strong evidence for androgen-driven acne without requiring hormone discontinuation. Management decisions should involve both the prescribing clinician and a licensed dermatologist, not esthetician-level care alone.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.

What did @theskinandlashlady actually say?

Amy, a licensed esthetician, is telling women who develop acne on hormone replacement therapy that their testosterone is the culprit and that her options are limited. Her core advice: either "remove the culprit" by stopping testosterone entirely or go back to your prescriber for a lower dose. She also mentions clients who quit testosterone and were "left with acne scarring." The framing is sympathetic but leans heavily toward discontinuation as the obvious fix.

To be fair, she does tell people to loop in their practitioner. That part is correct. But the overall message that stopping testosterone is the logical conclusion, and that there is little else to do, deserves more scrutiny than a 60-second TikTok provides.

Does the science back this up?

Partially. Androgens including testosterone do drive sebaceous gland activity, and acne is a documented side effect of testosterone therapy in women. But "remove the culprit" is a significant oversimplification of what the evidence actually supports.

Testosterone-related acne in women on HRT is real and documented. A 2019 review by Glintborg and colleagues in the journal Current Opinion in Endocrinology, Diabetes and Obesity confirmed that androgenic side effects, including acne and oily skin, occur in a subset of women using testosterone, particularly at supraphysiologic doses. But the same literature makes clear that dose optimization, not automatic discontinuation, is the first clinical step. Dermatological interventions, including topical retinoids, benzoyl peroxide, and in some cases spironolactone, can be effective alongside or instead of stopping testosterone. Spironolactone, an androgen receptor blocker, is specifically used to manage androgen-driven acne without requiring someone to abandon their hormonal therapy entirely. The idea that estheticians are the ceiling of available help is simply not true.

What did they get wrong (or right)?

She got the mechanism right. Testosterone increases sebum production via androgen receptors in the skin, which can trigger or worsen acne, especially in women who are sensitive to androgenic effects. That part checks out.

What she got wrong, or at least incomplete, is the claim that there is "very little" she or anyone else can do short of stopping the hormone. That framing ignores a whole category of medical dermatology options. Spironolactone has decades of evidence for androgen-driven acne. A 2017 randomized controlled trial by Santer et al. published in BMJ demonstrated meaningful acne reduction with low-dose spironolactone in adult women. Topical tretinoin and combination oral therapies also have strong support. Dose reduction of testosterone is a legitimate first move, but it is one option among several, not the final word. Framing discontinuation as "just what it is" could push someone off a therapy that has real benefits for their quality of life, libido, energy, and bone health.

What should you actually know?

If you are a woman on testosterone therapy and developing acne, this is a conversation for your prescribing clinician first, not your esthetician. Estheticians are skilled at topical skincare and aesthetic treatments, but they are not licensed to manage hormonally driven skin conditions or adjust your medication strategy.

Your prescriber can evaluate whether your testosterone levels are within an appropriate physiologic range for women, typically 15 to 70 ng/dL, and whether a dose adjustment is warranted. They can also refer you to a dermatologist who may recommend spironolactone, topical retinoids, or other evidence-based options. Discontinuing testosterone may be the right call for some people, but it should come after a clinical evaluation, not a TikTok. The acne scarring Amy mentions in her clients is a real risk, which is actually a reason to act faster with a dermatologist, not slower while waiting to see if quitting testosterone solves it.

One more thing worth saying plainly: acne from HRT is not inevitable and it is not untreatable. The research does not support the fatalistic framing that once hormones cause breakouts, you are stuck choosing between clear skin and your therapy.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @theskinandlashlady's HRT acne claims need context, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@theskinandlashlady's HRT acne claims need context is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

Compare providers, services and access requirements in the directory before contacting a suitable care team.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Claim verdict

The useful answer behind this video

Claim being checked

Testosterone therapy in women can increase sebaceous gland activity and trigger acne, particularly when doses push androgen levels above physiologic female ranges.

FormBlends verdict

Testosterone therapy in women can increase sebaceous gland activity and trigger acne, particularly when doses push androgen levels above physiologic female ranges. Dose reduction is a reasonable first clinical step, but dermatological options including topical retinoids and spironolactone have strong evidence for androgen-driven acne without requiring hormone discontinuation. Management decisions should involve both the prescribing clinician and a licensed dermatologist, not esthetician-level care alone.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Testosterone therapy in women can increase sebaceous gland activity and trigger acne, particularly when doses push androgen levels above physiologic female ranges. Dose reduction is a reasonable first clinical step, but dermatological options including topical retinoids and spironolactone have strong evidence for androgen-driven acne without requiring hormone discontinuation. Management decisions should involve both the prescribing clinician and a licensed dermatologist, not esthetician-level care alone.
  • Androgen-driven acne is a real side effect of testosterone therapy in women, documented in clinical reviews including Glintborg et al. (2019), but it is not universal or untreatable.
  • Spironolactone, an androgen receptor blocker, is a well-evidenced option for managing testosterone-related acne without discontinuing HRT. A 2017 BMJ RCT by Santer et al. showed meaningful improvement in adult female acne.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Androgen-driven acne is a real side effect of testosterone therapy in women, documented in clinical reviews including Glintborg et al. (2019), but it is not universal or untreatable.
  • Spironolactone, an androgen receptor blocker, is a well-evidenced option for managing testosterone-related acne without discontinuing HRT. A 2017 BMJ RCT by Santer et al. showed meaningful improvement in adult female acne.
  • Dose reduction is a legitimate first step, but it requires a prescribing clinician to evaluate whether levels are outside the physiologic female range before making changes.
  • Estheticians are not licensed to manage hormonally driven skin conditions or adjust hormone therapy. A dermatologist and prescribing clinician should be involved together.
  • Topical retinoids and other prescription-grade dermatology options can reduce acne severity and lower the risk of scarring even while hormone therapy continues.
  • Acne scarring risk is a reason to seek faster dermatological intervention, not to delay treatment while waiting to see if stopping testosterone resolves the issue.
  • Stopping testosterone entirely may be the right call for some patients, but that decision should follow a clinical evaluation of benefits versus side effects, not a social media recommendation.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Lic. Esthetician Amy · TikTok creator

7.4K views on this video

#hrt #hormonereplacementtherapy #acne

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Lic. Esthetician Amy, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.